File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Mechanisms of sympathetic enhancement and inhibition of parasympathetically induced salivary secretion in anaesthetized dogs

TitleMechanisms of sympathetic enhancement and inhibition of parasympathetically induced salivary secretion in anaesthetized dogs
Authors
Keywordsenhancement is via α1‐adrenoceptors whereas inhibition is via α2‐adrenoceptors.
Parasympathetic salivation
postsynaptic α1‐adrenoceptors
postsynaptic α2‐adrenoceptors
sympathetic enhancement of salivary flow
sympathetic inhibition of salivary flow
Issue Date1994
PublisherJohn Wiley & Sons Ltd. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=0007-1188&site=1
Citation
British Journal Of Pharmacology, 1994, v. 112 n. 2, p. 411-416 How to Cite?
AbstractThe effects of superimposed and continuous sympathetic nerve stimulation on submandibular parasympathetic salivation were investigated in anaesthetized dogs. Superimposed sympathetic nerve stimulation (1-2 min) initially enhanced and later inhibited salivary secretion induced by parasympathetic nerve stimulation (2-8 Hz) in glands with uncontrolled blood supply or constant-flow vascular perfusion. Propranolol 0.005 mg kg-1, i.a.) did not affect the diphasic sympathetic action whereas phentolamine (0.1 mg kg-1, i.a.) abolished it. Prazosin (0.025 mg kg-1, i.a.) greatly lessened the initial enhancement while yohimbine (0.025 mg kg-1, i.a.) alleviated the late inhibition. Salivary secretion, induced by parasympathetic nerve stimulation (4 Hz) or acetylcholine infusion (10 μg kg-1 min-1, i.a.), was abolished by atropine (0.05 mg kg-1, i.a.), increased by phenylephrine infusion (0.25 μg kg-1 min-1, i.a.) and depressed by clonidine infusion (0.75 μg kg-1 min-1, i.a.). Hexamethionium (12.5 mg kg-1, i.a.) abolished the nerve-induced secretion but had no effect on the acetylcholine-induced secretion. Continuous background sympathetic nerve stimulation decreased parasympathetic nerve-induced salivary secretion in glands with uncontrolled blood supply or constant-flow vascular perfusion. These results show that parasympathetic salivation can be modified by the sympathetic system at the postsynaptic level; enhancement is via α1-adrenoceptors whereas inhibition is via a2-adrenoceptors.
Persistent Identifierhttp://hdl.handle.net/10722/171607
ISSN
2023 Impact Factor: 6.8
2023 SCImago Journal Rankings: 2.119
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLung, MAen_US
dc.date.accessioned2012-10-30T06:15:56Z-
dc.date.available2012-10-30T06:15:56Z-
dc.date.issued1994en_US
dc.identifier.citationBritish Journal Of Pharmacology, 1994, v. 112 n. 2, p. 411-416en_US
dc.identifier.issn0007-1188en_US
dc.identifier.urihttp://hdl.handle.net/10722/171607-
dc.description.abstractThe effects of superimposed and continuous sympathetic nerve stimulation on submandibular parasympathetic salivation were investigated in anaesthetized dogs. Superimposed sympathetic nerve stimulation (1-2 min) initially enhanced and later inhibited salivary secretion induced by parasympathetic nerve stimulation (2-8 Hz) in glands with uncontrolled blood supply or constant-flow vascular perfusion. Propranolol 0.005 mg kg-1, i.a.) did not affect the diphasic sympathetic action whereas phentolamine (0.1 mg kg-1, i.a.) abolished it. Prazosin (0.025 mg kg-1, i.a.) greatly lessened the initial enhancement while yohimbine (0.025 mg kg-1, i.a.) alleviated the late inhibition. Salivary secretion, induced by parasympathetic nerve stimulation (4 Hz) or acetylcholine infusion (10 μg kg-1 min-1, i.a.), was abolished by atropine (0.05 mg kg-1, i.a.), increased by phenylephrine infusion (0.25 μg kg-1 min-1, i.a.) and depressed by clonidine infusion (0.75 μg kg-1 min-1, i.a.). Hexamethionium (12.5 mg kg-1, i.a.) abolished the nerve-induced secretion but had no effect on the acetylcholine-induced secretion. Continuous background sympathetic nerve stimulation decreased parasympathetic nerve-induced salivary secretion in glands with uncontrolled blood supply or constant-flow vascular perfusion. These results show that parasympathetic salivation can be modified by the sympathetic system at the postsynaptic level; enhancement is via α1-adrenoceptors whereas inhibition is via a2-adrenoceptors.en_US
dc.languageengen_US
dc.publisherJohn Wiley & Sons Ltd. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=0007-1188&site=1en_US
dc.relation.ispartofBritish Journal of Pharmacologyen_US
dc.subjectenhancement is via α1‐adrenoceptors whereas inhibition is via α2‐adrenoceptors.-
dc.subjectParasympathetic salivation-
dc.subjectpostsynaptic α1‐adrenoceptors-
dc.subjectpostsynaptic α2‐adrenoceptors-
dc.subjectsympathetic enhancement of salivary flow-
dc.subjectsympathetic inhibition of salivary flow-
dc.subject.meshAdrenergic Alpha-1 Receptor Antagonistsen_US
dc.subject.meshAdrenergic Alpha-2 Receptor Antagonistsen_US
dc.subject.meshAnesthesiaen_US
dc.subject.meshAnimalsen_US
dc.subject.meshBlood Pressure - Drug Effectsen_US
dc.subject.meshDogsen_US
dc.subject.meshElectric Stimulationen_US
dc.subject.meshFemaleen_US
dc.subject.meshMaleen_US
dc.subject.meshParasympathetic Nervous System - Drug Effects - Physiologyen_US
dc.subject.meshRegional Blood Flow - Drug Effectsen_US
dc.subject.meshSalivation - Drug Effects - Physiologyen_US
dc.subject.meshSubmandibular Gland - Blood Supply - Drug Effects - Secretionen_US
dc.subject.meshSympathetic Nervous System - Drug Effects - Physiologyen_US
dc.titleMechanisms of sympathetic enhancement and inhibition of parasympathetically induced salivary secretion in anaesthetized dogsen_US
dc.typeArticleen_US
dc.identifier.emailLung, MA:makylung@hkucc.hku.hken_US
dc.identifier.authorityLung, MA=rp00319en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1111/j.1476-5381.1994.tb13087.x-
dc.identifier.pmid8075858-
dc.identifier.scopuseid_2-s2.0-0028275527en_US
dc.identifier.volume112en_US
dc.identifier.issue2en_US
dc.identifier.spage411en_US
dc.identifier.epage416en_US
dc.identifier.isiWOS:A1994NN63600013-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridLung, MA=7006411781en_US
dc.identifier.issnl0007-1188-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats